These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4534 related articles for article (PubMed ID: 276347)

  • 21. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.
    Quirt IC; Shelley WE; Pater JL; Bodurtha AJ; McCulloch PB; McPherson TA; Paterson AH; Prentice R; Silver HK; Willan AR
    J Clin Oncol; 1991 May; 9(5):729-35. PubMed ID: 2016615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete remission of metastatic malignant melanoma following immunotherapy with Bacillus Calmette-Guerin (BCG): report of a case.
    Coates AS; Peters M
    Aust N Z J Surg; 1977 Jun; 47(3):362-5. PubMed ID: 269705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endolymphatic radionuclide therapy. Historical development and present status].
    Makoski HB; Magnus L; Scherer E; Stauch GW; Strötges MW
    Dtsch Med Wochenschr; 1973 Nov; 98(46):2207-13. PubMed ID: 4593334
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reliability of the diagnostic results obtained with confined quantities of the contrast medium in endolymphatic radionuclide therapy (ELRT) of the inferior limbs (author's transl)].
    Müller RP; Schnepper E; Peters PE; Fladerer W
    Strahlentherapie; 1980 Aug; 156(8):538-41. PubMed ID: 7414647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
    MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
    Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intralymphatic administration of BCG-CWS in advanced malignant melanoma].
    Mannami T; Matsumi A; Ichikawa J; Kagawa S; Orita K; Motoi M
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):85-90. PubMed ID: 7184364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Indications for and borderlines of endolymphatic therapy of melanoma and seminoma].
    Kärcher KH; Messeritsch M; Bardach G; Seitz W; Wolf G
    Strahlentherapie Sonderb; 1972; 72():261-72. PubMed ID: 4659340
    [No Abstract]   [Full Text] [Related]  

  • 28. Endolymphatic infusion of I-131 in the treatment of malignant melanoma: early experiences.
    Gibson T; Flatman GE; Orr JS
    Scott Med J; 1967 Jul; 13(7):226-31. PubMed ID: 4299291
    [No Abstract]   [Full Text] [Related]  

  • 29. Results of adjuvant BCG immunotherapy in malignant melanoma.
    Wätzig V; Knopf B
    Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The prevention of skin melanoma metastases to the regional lymph nodes].
    Korovin SI; Tolstopiatov BA
    Vrach Delo; 1990 Apr; (4):80-1. PubMed ID: 2275181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunotherapy of malignant melanoma].
    Adler A
    Harefuah; 1986 Jul; 111(1-2):11-7. PubMed ID: 3781371
    [No Abstract]   [Full Text] [Related]  

  • 32. Inconsistent response of B16 melanoma to BCG immunotherapy.
    Kreider JW; Bartlett GL; Purnell DM
    J Natl Cancer Inst; 1976 Apr; 56(4):803-10. PubMed ID: 1255799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study group--endolymphatic radionuclide therapy].
    Peters PE
    Med Welt; 1974 Jun; 25(23):1056-8. PubMed ID: 4411008
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781).
    Czarnetzki BM; Macher E; Suciu S; Thomas D; Steerenberg PA; Rümke P
    Eur J Cancer; 1993; 29A(9):1237-42. PubMed ID: 8343260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of BCG and C. parvum treatment on human melanoma xenografts.
    Garrett AJ; Reeson DE; Osborn TW; Boulger LR
    Dev Biol Stand; 1977 Apr 13-15; 38():363-8. PubMed ID: 608525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological aspects in the treatment of malignant melanoma].
    Cascinelli N; Vaglini M; Rovini D; Orefice S; Marolda R; Veronesi U
    Minerva Med; 1982 Apr; 73(18):1233-40. PubMed ID: 7078802
    [No Abstract]   [Full Text] [Related]  

  • 37. [Melanoma therapy].
    Kleeberg UR
    Dtsch Med Wochenschr; 1976 Jun; 101(23):904-8. PubMed ID: 773624
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combined treatment of patients with metastases of skin melanoma using cryotherapy].
    Iavorskiĭ VV; Karaseva VV; Tokareva ZI
    Vopr Onkol; 1988; 34(7):799-803. PubMed ID: 3420821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dosimetry in rabbit lymph nodes following endolymphatic therapy using radionuclides].
    Magnus L
    Strahlentherapie; 1973 Nov; 146(5):566-75. PubMed ID: 4362314
    [No Abstract]   [Full Text] [Related]  

  • 40. Mumps virus and BCG vaccine in metastatic melanoma.
    Minton JP
    Arch Surg; 1973 Apr; 106(4):503-6. PubMed ID: 4572347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 227.